This was the stock's fourth consecutive day of gains.

As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine By India Edwards HealthDay Reporter TUESDAY, Feb.

This was the stock's third consecutive day of gains.

Rancher has kept H5N1 at bay with a few relatively simple steps. Experts say avian influenza vaccine, long forbidden by trade ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade opportunity. Its discounted price combined with a long track record of steady growth, ...

Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.

Rule Breaker Investing has been built on episodic series. It's not true every week, but many a week we're adding the next ...

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting ...

BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 ...

TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a ...